• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS HBA1C III TINA-QUANT HEMOGLOBIN A1C III; ASSAY, GLYCOSYLATED HEMOGLOBIN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS HBA1C III TINA-QUANT HEMOGLOBIN A1C III; ASSAY, GLYCOSYLATED HEMOGLOBIN Back to Search Results
Catalog Number 05336163190
Device Problem High Test Results (2457)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 05/04/2018
Event Type  malfunction  
Manufacturer Narrative
(b)(4).
 
Event Description
The customer stated that they received questionable results for an unspecified number of patient samples tested for a1c-3 tina-quant hemoglobin a1c gen.3 (hba1c) on a cobas 6000 c (501) module - c501.Of the questioned samples, one patient sample had an erroneous hba1c result reported outside of the laboratory.The patient received treatment based on the erroneous result.The customer stated that the issue began when they started using a new reagent pack of the same lot number.No calibration was run on this new pack.Quality controls with an acceptable recovery were also not generated on the pack.The pack was on board the analyzer as a stand-by pack prior to being used.The sample initially resulted with an hba1c value of 6.8% and this value was reported outside of the laboratory.The sample was repeated, resulting as 5.3 %.The repeat result was believed to be correct.The patient received treatment for a diabetic protocol based on the erroneous result.The customer was asked, but could not provide any information on whether the patient was adversely affected due to this treatment.No adverse events were alleged to have occurred with the patient.The c501 analyzer serial number was (b)(4).The field application specialist was on site and instructed the customer to place a new reagent pack on board.The placed a new pack on board and ran controls.Controls passed and the customer did not encounter any further issues.The customer declined further service.
 
Manufacturer Narrative
The patient is not known to have diabetes.Other reagent packs from the same lot did not show any incorrect results at the customer site.A general reagent issue can be excluded.The customer did not use recommended rack adapters for 13 mm diameter tubes.The investigation was unable to find a definitive root cause.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HBA1C III TINA-QUANT HEMOGLOBIN A1C III
Type of Device
ASSAY, GLYCOSYLATED HEMOGLOBIN
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
MDR Report Key7532954
MDR Text Key109374625
Report Number1823260-2018-01577
Device Sequence Number1
Product Code LCP
Combination Product (y/n)N
PMA/PMN Number
K102914
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,user faci
Type of Report Initial,Followup
Report Date 06/04/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/22/2018
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date08/31/2019
Device Catalogue Number05336163190
Device Lot Number30116701
Date Manufacturer Received05/04/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age18 YR
-
-